This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignees: Ottawa Hospital Research Institute, Turnstone Biologics Corp.. Active years: 2023.
Company Filing History:
1 out of 33 
1 out of 2 Years Active: 2023
Title: The Innovative Contributions of Matthew Y Tang
Introduction
Matthew Y Tang is a notable inventor based in Orleans, California. He has made significant strides in the field of medical research, particularly in the development of modified orthopoxvirus vectors for cancer treatment. His work has the potential to revolutionize therapeutic approaches to various cancers.
Latest Patents
Matthew Y Tang holds a patent for modified orthopoxvirus vectors. This patent relates to the use of these vectors for the treatment of various cancers. The modified orthopoxvirus vectors exhibit beneficial therapeutic activities, including enhanced oncolytic activity, improved spread of infection, immune evasion, tumor persistence, and the capacity for incorporating exogenous DNA sequences. Additionally, these vectors are amenable to large-scale manufacturing protocols, making them a promising avenue for cancer therapy.
Career Highlights
Throughout his career, Matthew has worked with esteemed organizations such as the Ottawa Hospital Research Institute and Turnstone Biologics Corporation. His contributions to these institutions have been instrumental in advancing cancer research and treatment methodologies.
Collaborations
Matthew has collaborated with notable colleagues, including John Cameron Bell and Fabrice Le Boeuf. These partnerships have further enriched his research and innovation efforts.
Conclusion
Matthew Y Tang's innovative work in the field of modified orthopoxvirus vectors showcases his commitment to advancing cancer treatment. His contributions are paving the way for new therapeutic strategies that could significantly impact patient care.